CClinicalTrials.gg
Status unknownNCT01775150Updated Jan 24, 2013

Saving Mother and Baby With Text Messaging

An interventional study of health education in Bleeding, Infection and Malnutrition, sponsored by Ottawa Hospital Research Institute. Status unknown at 1 site in Canada. Open to female participants aged 16 Years to 45 Years. Per ClinicalTrials.gov, last updated 2013-01-24.

Sponsored by Ottawa Hospital Research Institute · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Jan 2013), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
5,646
Allocation
Randomized
Ages
16 Years to 45 Years
Sex
Female
01

Study summary

We plan to integrate WHO educational material using mobile phone text messaging, target on pregnant women in remote rural areas in China. We hypothsized that text messaging can have major impact on reducing maternal and infant deaths in rural China because text messaging is accessible, acceptable, and affordable.

Read the detailed description
  1. Sampling method:

    Random sampling method will be used. Counties in Huaihua area of Chinese province of Hunan will be randomly allocated to intervention and non-intervention groups.

  2. The intervention:

    Mobile phone text messages containing maternal and newborn health care education material will be sent to mothers-to-be at the first, second and third trimester, and again postpartum period.

  3. Statistical analysis:

We will first compare the baseline characteristics (including the average income, adult educational level, and maternal and perinatal mortality rates in the past two years) between the 2 arms of experiment. For costs data, total costs, costs per participating woman, and costs per maternal/infant death avoided will be reported. For primary outcomes, we will determine and report rate ratios, risk differences, and numbers needed to treat (NNT) from the experimental arm (i.e., mobile phone text messaging), using the usual care arm (no text messaging) as the reference. Relative risks and 95% confidence intervals will be expressed as the effect measures. We will estimate the adjusted relative risks and 95% confidence intervals by regression analysis. Mixed models taking consideration of multi-level measures (e.g., mortality and morbidity measured at individual level and intervention measured at village level) will be used in the regression analysis (Donner and Klar, 2000).

02

Conditions studied

  • Bleeding
  • Infection
  • Malnutrition
  • Complications

Browse trials for

Keywords

  • mobile phone text messaging
  • maternality
  • infant
  • death rate
03

In context

Malnutrition

1,587 studies on the registry are indexed under Malnutrition; 237 are open to participants now.

This study's planned enrollment of 5,646 is above the median of 90 across 1,134 interventional studies indexed under Malnutrition.

Browse Malnutrition studies →

Lead sponsor

Ottawa Hospital Research Institute is the lead sponsor of 538 studies on the registry; 100 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • women who were registered by local Maternal Child Health unit during the study period

Exclusion criteria

Exclusion Criteria:

05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
5,646 participants (estimated)

Study arms

  • Experimental
    health education

    health education via text messaging

    Other: health education

  • No intervention
    no health education

    no health education via text messaging

Interventions

  • Otherhealth education

    Health education via text messaging

06

What researchers measure

Primary outcomes

  1. Neonatal death

    28 days after birth

    Time frame: 28 days

Secondary outcomes

  1. Maternal death

    From conception to 42 days postpartum

    Time frame: 300 days

07

Study locations

1 site
  • Ottawa Hospital Research Institue
    Ottawa, Ontario K1H8L6, Canada
08

References and documents

Publications

  • Palmer MJ, Henschke N, Bergman H, Villanueva G, Maayan N, Tamrat T, Mehl GL, Glenton C, Lewin S, Fonhus MS, Free C. Targeted client communication via mobile devices for improving maternal, neonatal, and child health. Cochrane Database Syst Rev. 2020 Jul 14;8(8):CD013679. doi: 10.1002/14651858.CD013679. PubMed 32813276 ↗
  • Xie RH, Tan H, Taljaard M, Liao Y, Krewski D, Du Q, Wen SW. The Impact of a Maternal Education Program Through Text Messaging in Rural China: Cluster Randomized Controlled Trial. JMIR Mhealth Uhealth. 2018 Dec 19;6(12):e11213. doi: 10.2196/11213. PubMed 30567693 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01775150
Lead sponsor
Ottawa Hospital Research Institute
Collaborators
Canadian International Development Agency, Canadian Institutes of Health Research (CIHR), Bill and Melinda Gates Foundation
Responsible party
Sponsor
First posted
Jan 24, 2013
Start date
Oct 2011
Primary completion
Mar 2013 (estimated)
Completion
May 2013 (estimated)
Last update
Jan 24, 2013

Study contacts

Rihua Xie, PhD
principal investigator · Ottawa Hospital Research Institute
Shi Wu Wen, PhD
study director · Ottawa Hospital Resarch Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion